Age Old Stock Fundamentals
AGEDelisted Stock | USD 0.74 0.01 1.37% |
AGE Old fundamentals help investors to digest information that contributes to AGE Old's financial success or failures. It also enables traders to predict the movement of AGE Stock. The fundamental analysis module provides a way to measure AGE Old's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to AGE Old stock.
AGE |
AGE Old Company Shares Owned By Insiders Analysis
AGE Old's Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current AGE Old Shares Owned By Insiders | 75.73 % |
Most of AGE Old's fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, AGE Old is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
CompetitionBased on the latest financial disclosure, 75% of AGE Old are shares owned by insiders. This is 398.88% higher than that of the Biotechnology sector and notably higher than that of the Health Care industry. The shares owned by insiders for all United States stocks is notably lower than that of the firm.
AGE Old Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining AGE Old's current stock value. Our valuation model uses many indicators to compare AGE Old value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across AGE Old competition to find correlations between indicators driving AGE Old's intrinsic value. More Info.AGE Old is rated below average in return on asset category among its peers. It is rated below average in operating margin category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value AGE Old by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.AGE Shares Owned By Insiders Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses AGE Old's direct or indirect competition against its Shares Owned By Insiders to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of AGE Old could also be used in its relative valuation, which is a method of valuing AGE Old by comparing valuation metrics of similar companies.AGE Old is currently under evaluation in shares owned by insiders category among its peers.
AGE Fundamentals
Return On Asset | -0.82 | |||
Operating Margin | (63.57) % | |||
Current Valuation | 33.33 M | |||
Shares Outstanding | 2.5 M | |||
Shares Owned By Insiders | 75.73 % | |||
Shares Owned By Institutions | 5.64 % | |||
Number Of Shares Shorted | 4.47 K | |||
Price To Earning | (5.95) X | |||
Price To Book | 12.96 X | |||
Price To Sales | 221.90 X | |||
Revenue | 142 K | |||
Gross Profit | 125 K | |||
EBITDA | (9.83 M) | |||
Net Income | (14.8 M) | |||
Cash And Equivalents | 645 K | |||
Cash Per Share | 0.02 X | |||
Total Debt | 4.37 M | |||
Debt To Equity | 0.75 % | |||
Current Ratio | 0.19 X | |||
Book Value Per Share | 5.07 X | |||
Cash Flow From Operations | (7.8 M) | |||
Short Ratio | 3.88 X | |||
Earnings Per Share | (13.36) X | |||
Beta | 1.19 | |||
Market Capitalization | 31.51 M | |||
Total Asset | 11.96 M | |||
Retained Earnings | (131.01 M) | |||
Working Capital | (5.16 M) | |||
Current Asset | 5.06 M | |||
Current Liabilities | 5.17 M | |||
Z Score | -14.21 | |||
Net Asset | 11.96 M |
About AGE Old Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze AGE Old's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AGE Old using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AGE Old based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States. AgeX Therapeutics, Inc. was incorporated in 2017 and is based in Alameda, California. Agex Therapeutics operates under Biotechnology classification in the United States and is traded on AMEX Exchange. It employs 5 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Consideration for investing in AGE Stock
If you are still planning to invest in AGE Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the AGE Old's history and understand the potential risks before investing.
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |